Matches in Wikidata for { <http://www.wikidata.org/entity/Q66042768> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q66042768 description "clinical trial" @default.
- Q66042768 description "ensayu clínicu" @default.
- Q66042768 description "klinisch onderzoek" @default.
- Q66042768 description "клінічне випробування" @default.
- Q66042768 name "Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma" @default.
- Q66042768 name "Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma" @default.
- Q66042768 type Item @default.
- Q66042768 label "Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma" @default.
- Q66042768 label "Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma" @default.
- Q66042768 prefLabel "Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma" @default.
- Q66042768 prefLabel "Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma" @default.
- Q66042768 P1050 Q66042768-2D7CC523-5A19-4058-93AE-51DD9540DA57 @default.
- Q66042768 P1132 Q66042768-4D404A79-7553-428C-8347-EFFF98F20640 @default.
- Q66042768 P1476 Q66042768-5E65EFAC-D100-41DA-A307-5B42B8030782 @default.
- Q66042768 P17 Q66042768-AADA88FE-EC49-49AC-825E-E05DA37DE9B0 @default.
- Q66042768 P2899 Q66042768-34712D70-EB79-4BC0-99BC-C80FB249FA86 @default.
- Q66042768 P3098 Q66042768-98F4DA4C-8BA7-4201-B678-0D2D6A0DE1EF @default.
- Q66042768 P31 Q66042768-307DB3EE-AC38-4B40-8D5E-A1F7FD0877F8 @default.
- Q66042768 P4844 Q66042768-006DDBA6-5481-472F-8C8B-50A567D7FF89 @default.
- Q66042768 P580 Q66042768-2D1DE848-BB5E-43D4-BB6B-B3B287B0C700 @default.
- Q66042768 P582 Q66042768-B8050297-5998-4758-9822-D0B9B51F1E1C @default.
- Q66042768 P6099 Q66042768-374AE80F-99CB-4E77-A7AE-7E40CC9B360A @default.
- Q66042768 P6153 Q66042768-CBBCF99B-1AC8-4A73-8F8D-097ED20588CA @default.
- Q66042768 P8363 Q66042768-E7700ADC-F84C-46B9-B737-A056AA4455BB @default.
- Q66042768 P1050 Q609503 @default.
- Q66042768 P1132 "+90" @default.
- Q66042768 P1476 "Phase II Study of Pembrolizumab (MK-3475) in Combination With Standard Therapy for Newly Diagnosed Glioblastoma" @default.
- Q66042768 P17 Q30 @default.
- Q66042768 P2899 "+18" @default.
- Q66042768 P3098 "NCT03197506" @default.
- Q66042768 P31 Q30612 @default.
- Q66042768 P4844 Q13896859 @default.
- Q66042768 P580 "2017-09-15T00:00:00Z" @default.
- Q66042768 P582 "2022-07-31T00:00:00Z" @default.
- Q66042768 P6099 Q42824440 @default.
- Q66042768 P6153 Q1130172 @default.
- Q66042768 P8363 Q78089383 @default.